Ocrevus Now Approved Website (Patient and HCP) May 9, 2017 Brand: Ocrevus (ocrelizumab), Intravenous Infusion Parent Company: Genentech Drug Type: Prescription Drug Category: Neurology Campaign: now-approved Targeting: HCPs, Patients Patient Website: https://www.ocrevus.com/patient.html HCP Website: https://www.ocrevus.com/hcp.html Patient Homepage Patient Resources HCP Homepage HCP Dosing Page